Want to see IN:MEDANTA full AI Analyst Report?
MEDANTA Stock Chart & Stats
₹1370.40
₹36.20(2.64%)
At close: 4:00 PM EDT
₹1370.40
₹36.20(2.64%)
Day’s Range― - ―
52-Week Range₹955.20 - ₹1,490.00
Previous CloseN/A
Volume320.04K
Average Volume (3M)17.50K
Market Cap
₹379.36B
Enterprise Value₹350.31K
Total Cash (Recent Filing)₹11.30B
Total Debt (Recent Filing)₹11.90B
Price to Earnings (P/E)68.7
Beta0.67
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)20.71
Shares Outstanding268,871,800
10 Day Avg. Volume39,597
30 Day Avg. Volume17,497
Financial Highlights & Ratios
PEG Ratio2.98
Price to Book (P/B)6.52
Price to Sales (P/S)5.86
P/FCF Ratio-114.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,660.00Price Target Upside21.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)26.66
Revenue Forecast (FY)₹53.10B
Bulls Say, Bears Say
Bulls Say
Consistent Multi-year Revenue GrowthSustained double-digit revenue growth over multiple years indicates durable demand for tertiary/quaternary services and effective market penetration. This trend supports long-term capacity utilization, pricing power in complex care, and predictable top-line expansion over the next 2–6 months and beyond.
Scaled Profitability And Operating StrengthRising net income and solid operating profit point to operating leverage as volumes and case complexity grow. Sustained profitability improvements enhance reinvestment capability and return on capital, supporting durable margin recovery and strategic investments over medium term.
Improved Leverage And Stronger Balance Sheet HistoryA rising equity base and materially lower leverage versus prior cyclical peaks provide financial flexibility and resilience. This stronger capital structure supports capacity expansion, absorbes shocks, and lowers refinancing risk, underpinning medium-term strategic execution.
Bears Say
Free Cash Flow Turned Negative In 2026A swing to negative free cash flow reduces near-term financial flexibility and increases reliance on external funding to support growth or debt servicing. If higher capex or working capital persists, cash constraints could limit strategic initiatives or elevate refinancing needs over the next several quarters.
Total Debt Increased In 2026 Versus 2025An uptick in debt after prior deleveraging raises the risk that leverage could drift higher, pressuring interest costs and flexibility. Persistent debt growth alongside negative FCF could strain the balance sheet and constrain capital allocation over the medium term.
Margin Volatility And Lower Gross Profit In 2026A decline in gross profit despite rising revenue signals cost or mix headwinds that can erode sustainable margins. Continued margin volatility would weaken cash conversion and returns, making long-term profitability and investment planning less predictable.
Global Health Limited News
MEDANTA FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest stock price was ₹955.20 and its highest was ₹1490.00 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is ₹379.36B.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is Nov 06, 2026 which is in 83 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Jul 30, 2026. The company reported ₹5.9 earnings per share for the quarter, beating the consensus estimate of ₹5.41 by ₹0.49.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Undervalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of 0.07%. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 268,871,800 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of ₹5.9 in its last earnings report, beating expectations of ₹5.41. Following the earnings report the stock price went down -1.187%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in IN:MEDANTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Health Limited
Operating throughout India, Global Health Limited, known by its Medanta brand, stands as a prominent multi-specialty tertiary care provider. The company delivers a comprehensive suite of healthcare services, with particular expertise in cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, as well as kidney and urology treatments. Established in 2004 and headquartered in Gurgaon, India, it operates a network of four hospitals strategically located in Gurugram, Indore, Ranchi, and Lucknow.
MEDANTA Stock 12 Month Forecast
Average Price Target
₹1,660.00
▲(21.13% Upside)
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Narayana Hrudayalaya Ltd.
―






